<DOC>
	<DOCNO>NCT00684164</DOCNO>
	<brief_summary>Low sodium level ( hyponatremia ) frequent occurrence medically ill patient , particular neurological injury . Hyponatremia associate bad outcome , problem memory concentration impaired balance . Standard treatment low sodium ( salt ) level give patient salt contain solution thru catheter ( small flexible tube ) vein arm leg . One major complication treatment excess body fluid may cause heart problem accumulation fluid lung may require additional medication remove extra water body . FDA approval recently grant new drug - Conivaptan - use hyponatremic condition . Conivaptan work excrete free water body thereby produce concurrent rise serum sodium concentration . Conivaptan evaluate specifically patient brain injury . The primary objective study demonstrate safety efficacy intravenous Conivaptan treatment hyponatremia patient brain injury . If effective , Conivaptan may represent safe treatment option .</brief_summary>
	<brief_title>Safety Efficacy Conivaptan Correction Hyponatremia Neurological Patients</brief_title>
	<detailed_description />
	<mesh_term>Hyponatremia</mesh_term>
	<mesh_term>Conivaptan</mesh_term>
	<criteria>Acute neurological injury Euvolemia hypervolemia ( define clinically examination , recent I+Os , BUN/creatinine ratio CVP [ available ] ) Serum sodium less equal 132 mEq/L ( confirm hypoosmolar hyponatremia concurrent source : osmolality measurement [ &lt; 280 mosoms/L ] precede serum Na+ value &lt; 135 mEq/L0 Patients uncontrolled hypertension ; significant orthostatic hypotension supine systolic blood pressure le 85 mm Hg ; Uncontrolled arrhythmia ; Untreated severe hypothyroidism , hyperthyroidism , adrenal insufficiency ; Estimated creatinine clearance le 20 ml/min ; Urinary outflow obstruction unless catheterize ; Alanine aminotransferase ( ALT ) &gt; 3x ULN Aspartate aminotransferase ( AST ) &gt; 3x ULN Serum albumin 1.5 g/dl less ; Prothrombin time great 22 sec international normalize ratio ( INR ) great 2.0 without anticoagulant therapy 3.0 therapy ; white blood cell count le 3000/Âµl ; HIV infection ; Active hepatitis . Pregnant nursing Participation clinical trial investigational drug device within 30 day screen Unable obtain write consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Euvolemic Hyponatremia</keyword>
	<keyword>Hypervolemic Hyponatremia</keyword>
	<keyword>Neurological injury</keyword>
</DOC>